132 related articles for article (PubMed ID: 16973520)
1. Icodextrin increases natriuretic peptides in diabetic patients undergoing CAPD.
Bouchi R; Babazono T; Inoue A; Tanaka M; Tanaka N; Hase M; Ishii A; Iwamoto Y
Perit Dial Int; 2006; 26(5):604-7. PubMed ID: 16973520
[No Abstract] [Full Text] [Related]
2. Novel approaches to prescribing icodextrin.
Blake PG
Perit Dial Int; 2009; 29(4):412-4. PubMed ID: 19602606
[No Abstract] [Full Text] [Related]
3. The use of exchange-free periods alternating with daily exchanges of icodextrin in the initial treatment of peritoneal dialysis-associated peritonitis: a safety study.
Yehia M; Muyoma G; Topley N; Collins JF
Perit Dial Int; 2014; 34(7):810-3. PubMed ID: 25520490
[No Abstract] [Full Text] [Related]
4. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
[TBL] [Abstract][Full Text] [Related]
5. Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH).
de Moraes TP; Andreoli MC; Canziani ME; da Silva DR; Caramori JC; Ponce D; Cassi HV; de Andrade Bastos K; Rio DR; Pinto SW; Filho SR; de Campos LG; Olandoski M; Divino-Filho JC; Pecoits-Filho R
Nephrol Dial Transplant; 2015 Nov; 30(11):1905-11. PubMed ID: 26063787
[TBL] [Abstract][Full Text] [Related]
6. Ten years after MIDAS: icodextrin lights and shadows.
Amici G; Da Rin G; Agostini A; Velo S; Bocci C
Contrib Nephrol; 2003; (140):76-81. PubMed ID: 12800346
[No Abstract] [Full Text] [Related]
7. Effect of icodextrin dialysis solution on body weight and fat accumulation over time in CAPD patients.
Cho KH; Do JY; Park JW; Yoon KW
Nephrol Dial Transplant; 2010 Feb; 25(2):593-9. PubMed ID: 19767632
[TBL] [Abstract][Full Text] [Related]
8. Icodextrin's effects on peritoneal transport.
Krediet RT; Ho-dac-Pannekeet MM; Imholz AL; Struijk DG
Perit Dial Int; 1997; 17(1):35-41. PubMed ID: 9068020
[TBL] [Abstract][Full Text] [Related]
9. How to improve survival in geriatric peritoneal dialysis patients.
Hiramatsu M;
Perit Dial Int; 2007 Jun; 27 Suppl 2():S185-9. PubMed ID: 17556302
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure.
Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
Perit Dial Int; 2009; 29(1):116-8. PubMed ID: 19164263
[No Abstract] [Full Text] [Related]
11. Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis.
Orihuela O; de Jesús Ventura M; Ávila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Alcántara G; Lindholm B; García-López E; Villanueva C; Paniagua R
Perit Dial Int; 2014; 34(1):57-63. PubMed ID: 24525598
[TBL] [Abstract][Full Text] [Related]
12. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients.
Paniagua R; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Orihuela O; Prado-Uribe MD; Alcántara G; Amato D
Perit Dial Int; 2009; 29(4):422-32. PubMed ID: 19602608
[TBL] [Abstract][Full Text] [Related]
13. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis.
Paniagua R; Orihuela O; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Prado-Uribe MD; Alcántara G; Amato D
Kidney Int Suppl; 2008 Apr; (108):S125-30. PubMed ID: 18379535
[TBL] [Abstract][Full Text] [Related]
14. Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
Babazono T; Nakamoto H; Kasai K; Kuriyama S; Sugimoto T; Nakayama M; Hamada C; Furuya R; Hasegawa H; Kasahara M; Moriishi M; Tomo T; Miyazaki M; Sato M; Yorioka N; Kawaguchi Y;
Am J Nephrol; 2007; 27(4):409-15. PubMed ID: 17622748
[TBL] [Abstract][Full Text] [Related]
15. Icodextrin-associated peritonitis among CAPD patients.
Seow YY; Iles-Smith H; Hirst H; Gokal R
Nephrol Dial Transplant; 2003 Sep; 18(9):1951-2. PubMed ID: 12937264
[No Abstract] [Full Text] [Related]
16. Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis.
Takeguchi F; Nakayama M; Nakao T
Ther Apher Dial; 2008 Jun; 12(3):243-9. PubMed ID: 18503703
[TBL] [Abstract][Full Text] [Related]
17. The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis.
Pawlaczyk K; Garcia-Lopez E; Kuzlan-Pawlaczyk M; Heimbürger O; Bergström J; Breborowicz A; Lindholm B
Perit Dial Int; 2001; 21 Suppl 3():S359-61. PubMed ID: 11887855
[TBL] [Abstract][Full Text] [Related]
18. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
Canbakan M; Sahin GM
Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
[TBL] [Abstract][Full Text] [Related]
19. Influence of icodextrin on plasma and dialysate levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine.
Konings CJ; Schalkwijk CG; van der Sande FM; Leunissen KM; Kooman JP
Perit Dial Int; 2005; 25(6):591-5. PubMed ID: 16411527
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal reaction to icodextrin in a female patient on CAPD.
Heering P; Brause M; Plum J; Grabensee B
Perit Dial Int; 2001; 21(3):321-2. PubMed ID: 11475354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
